close
Terms of Use and Privacy Notice

Legal

Please read these Terms of Use and Privacy Notice (hereafter "Terms of Use") carefully before browsing the European Federation of Biotechnology website with address www.efbiotechnology.org (the "Website"). This site is owned and operated by the "European Federation of Biotechnology", in short "EFB", an international not for profit association with registered office at Gran Vía Carlos III, 98, Torre Norte, Planta 10, 08028 Barcelona, Spain. Tel: +34 93 521 1153.



1. General terms

These Terms of Use apply to any person accessing the Website (hereafter a "User") and may be changed in full or in part by EFB at all times and without notice. Regular consultation of these Terms of Use is therefore recommended, in order to remain up to date with the latest version. By using this Website, the User fully and unconditionally accepts the present Terms of Use and undertakes to comply with them. If the User does not agree with these Terms of Use, he shall refrain from making any use whatsoever of the Website. In case of a breach of these Terms of Use or of any other contractual obligation between the User and EFB, EFB reserves the right to refuse access to the Website (including, without limitation the Restricted Area, as defined below) without prejudice to the right of EFB or any third party to claim compensation for all direct and indirect damage sustained as a result of the breach.



2. Conditions of access to the extranet area

Access to the extranet area of the website is restricted to EFB members and therefore cannot be accessed by any other users of the website. Access shall be conditional to obtaining a username and password from EFB.



3. Content

The information and material contained in this Website is for information only. It is offered in the utmost good faith. The information it contains is believed to be correct. Nevertheless EFB makes no representation or warranties as to the adequacy, reliability, currency, completeness or accuracy of any information presented on this Website (or any linked site), neither does it assume any liability for any inaccuracy or incompleteness found in the content. Barring deliberate acts and/or mandatory legal provisions, EFB will in no event be held responsible for any use made of the content of this Website. Neither will it be held liable for any loss or damage of any nature whatsoever (direct, indirect, material or immaterial, etc.) resulting from the use of or reliance on the information presented on this Website.

EFB reserves the right to amend and update this website at any time without prior notice. The user acknowledges that EFB reserves its right to modify the website and its content at any time and without prior notice.



4. Security

EFB applies a range of security controls to protect the Website from unauthorized access. However, EFB does not guarantee that the Website will be secure or free from bugs or viruses. EFB accepts no liability for any interference with or damage to a User's computer system, software or data occurring in connection with or relating to this Website or its use. Users are encouraged to take appropriate and adequate precautions (such as having their own virus protection software) to ensure that whatever is selected from this site is free of viruses or other contamination that may interfere with or damage the User's computer system, software or data. Users are responsible for configuring their information technology, computer programmes and platform in order to access the Website. Users must not misuse the Website by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. Users must not attempt to gain unauthorised access to the Website, the server on which the Website is stored or any server, computer or database connected to the Website. Users must not attack the Website via a denial-of-service attack or a distributed denial-of service attack. EFB will report any such breach to the relevant law enforcement authorities and will co-operate with those authorities.



5. Privacy

To use most of this Website, you do not need to provide EFB with any personal data. However, we do collect personal data with your consent when you send a query to through our content form. Your personal data will only be used by EFB to administer the service that you have requested. When you provide personal information to EFB for any of the above reasons, we will take all necessary steps and use the best security measures to protect your personal data against loss, misuse and alteration. EFB will not give away or sell your personal data to third parties. EFB respects your privacy and only uses your information for quick and easy communication: information and answers to your queries, electronic communications (press releases, newsletters, etc.), comments and suggestions. All personal data that we gain from personal contacts, mailings and the website are structurally recorded by EFB and is not passed on to third parties. If you want to view your data, you can make a request to EFB, Gran Vía Carlos III, 98, Torre Norte, Planta 10, 08028 Barcelona (Spain), phone +34 93 521 1153 or by e-mail at info@efbiotechnology.org.

afob

Event Events

Events

Beyond COVID-19 Access to Medicines and Vaccines in Asia

AFOB hit 50224 date 2021-02-22 11:22
 
휴먼아시아는 아래와 같이 의약품 접근(A2M) 포럼을 개최하여 대한민국과 COVID-19 의약품 및 기타 필수 의약품에 대한 담론을 활성화하고자 합니다.
Human Asia would like to hold a Pharmaceutical Access (A2M) forum as below to promote discourse on COVID-19 medicines and other essential medicines.
▶️행사명: 「의약품 접근(A2M) 포럼」 포스트 코로나19 시대, 아시아 의약품 및 백신 접근성 현황과 개선방안  
▶️일시: 2021년 3월 5일 금요일 10:00 AM ~ 17:00 PM (한국표준시간)
▶️장소: 글래드 여의도 (서울 영등포구 소재) 내 B1층 블룸 홀
▶️주최: 휴먼아시아, UAEM Korea, 한국인권학회 
▶️언어: 한국어 & 영어 (동시통역 제공)
▶️TITLE:Access to medications(A2M) Forum」 Beyond COVIE-19 Access to Medicines and Vaccines in Asia
▶️DATE: 2021년 3월 5일 금요일 10:00 AM ~ 17:00 PM (한국표준시간)
▶️WHERE: Bloom Hall on B1F in Yeouido, Seoul
▶️HOST: Humanasia, UAEM Korea, KAHRS
▶️LANGUAGE: KOREAN & ENGLISH (Simultaneous interpretation provided)
* 사전등록링크(Registeration Link): https://bit.ly/A2Mforum
● 「의약품 접근(A2M) 포럼」 오프라인 참가를 희망하시는 분은 2021년 02월 26일 까지 온라인 링크를 통해 사전등록 부탁드립니다. 선착순 30명에 한해 진행되며, 방역 수칙에 따라 현장 참석 인원 수가 줄어들 수도 있습니다. 
Those who wish to participate offline, please register in advance through the online link by February 26, 2021. It's only for the first 30 people, and the quarantine rules may reduce the number of people attending the site.
● 「의약품 접근(A2M) 포럼」 의 온라인 참가를 희망하시는 분 역시 2021년 03월 04일까지 링크를 통해 사전등록 부탁드립니다. 사전등록자에 한하여만 참석이 가능하며, 현장등록은 진행하지 않습니다.
Those who wish to participate online, please register in advance through the link by 03/04/21. Only pre-registrants can attend, but on-site registration is not available.
● 주차 자리가 협소한 관계로, 오프라인 참석자에게 주차는 제공되지 않습니다. 대중교통이나 택시 등의 교통 수단을 이용하시는 것을 권장드립니다.
Parking is not available to offline attendees because of the limited parking space. It is recommended that you use public transportation or taxi.
● 사전등록 시 기입하신 정보로 오프라인/온라인 참석을 위한 정보가 전달 될 예정입니다. 원활한 포럼 진행을 위해 연락처(이메일, 전화번호)를 정확히 작성해주시기 바랍니다.
The information you filled out during pre-registration will be delivered to you for offline/online attendance. Please fill out the contact information (email, phone number) to facilitate the forum.
* 추후 프로그램(주제, 패널 등)이 변경될 수 있으며, 참고해주시기 바랍니다. 
 The program (topic, panel, etc.) may be changed in the future, and please refer to it.
file
no file.
삼성바이오
c1
GC
celltrion
lgchem
eubiologics
sartorius